SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aurobindo Pharma gets warning letter from USFDA

24 May 2011 Evaluate

Drug-maker Aurobindo Pharma has received a warning letter from the US health regulator with regard to its antibiotics manufacturing unit in Hyderabad. The company had earlier received an import alert in February this year from the US Food and Drug Administration (USFDA) for its cephalosporin-producing Unit VI located at Chitkul Village, in Hyderabad, Andhra Pradesh. The company has now received the warning letter from the USFDA detailing their observations.

In addition, based on a field alert report related to non-compliance with packaging and labelling norms at Unit III of the facility, the USFDA has asked Aurobindo Pharma to submit a detailed action plan on rectifying the situation. Aurobindo Pharma is required to submit the action plan to the USFDA within 15 working days. The company has also been given an opportunity for a regulatory meeting with the USFDA at their office. The company is requesting USFDA for the meeting date, (and is) in the process of submitting a detailed action plan. The USFDA had audited Unit VI of the Hyderabad-based firm in the month of December, 2010. Subsequent to the audit findings, the USFDA had imposed an import alert for detention of Unit VI products.

crackcrack

Aurobindo Pharma Share Price

1407.15 16.00 (1.15%)
22-Apr-2026 11:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1660.85
Dr. Reddys Lab 1220.20
Cipla 1231.15
Zydus Lifesciences 930.70
Lupin 2313.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×